Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 373 entries
View as:

Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants

Phase: N/A Priority: Normal
NCT ID: NCT01446926 Org: User:
Start: 09/30/11 End: 06/30/13 Due: 06/30/14

Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™

Phase: N/A Priority: Normal
NCT ID: NCT00534833 Org: User:
Start: 09/30/07 End: 03/31/09 Due: 03/31/10

Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

Phase: N/A Priority: Normal
NCT ID: NCT06647407 Org: User:
Start: 11/05/24 End: 05/17/27 Due: 05/17/28

Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02587520 Org: User:
Start: 10/22/15 End: 02/21/17 Due: 02/21/18

Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT01945424 Org: User:
Start: 08/16/13 End: 09/15/19 Due: 09/15/20

Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT00389103 Org: User:
Start: 10/31/06 End: 01/31/07 Due: 01/31/08

Post-licensure Safety Study of IMOJEV® in Thailand

Phase: N/A Priority: Normal
NCT ID: NCT01981967 Org: User:
Start: 11/30/13 End: 10/31/15 Due: 10/31/16

Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT06118151 Org: User:
Start: 04/11/22 End: 02/17/23 Due: 02/17/24

Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children

Phase: N/A Priority: Normal
NCT ID: NCT00491985 Org: User:
Start: 06/30/07 End: 06/30/10 Due: 06/30/11

Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01930357 Org: User:
Start: 09/30/13 End: 06/30/15 Due: 06/30/16

Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants

Phase: N/A Priority: Normal
NCT ID: NCT00401531 Org: User:
Start: 10/31/06 End: 08/31/08 Due: 08/31/09

Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00313950 Org: User:
Start: 09/30/06 End: 04/30/10 Due: 04/30/11

Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00613509 Org: User:
Start: 06/30/08 End: 06/30/10 Due: 06/30/11

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT03698279 Org: User:
Start: 10/09/18 End: 10/16/19 Due: 10/16/20

Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT02610348 Org: User:
Start: 11/30/15 End: 03/31/16 Due: 03/31/17

Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00772629 Org: User:
Start: 01/31/04 End: 04/30/04 Due: 04/30/05

Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT01436396 Org: User:
Start: 09/07/11 End: 09/02/13 Due: 09/02/14

Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00258817 Org: User:
Start: 10/31/05 End: 08/31/07 Due: 08/31/08

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Phase: N/A Priority: Normal
NCT ID: NCT05794230 Org: User:
Start: 03/27/23 End: 12/02/25 Due: 12/02/26

Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01442675 Org: User:
Start: 09/30/11 End: 12/31/12 Due: 12/31/13

Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Route)

Phase: N/A Priority: Normal
NCT ID: NCT01121822 Org: User:
Start: 05/31/10 End: 06/30/10 Due: 06/30/11

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT01839175 Org: User:
Start: 04/30/13 End: 02/28/15 Due: 02/28/16

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT03691610 Org: User:
Start: 10/04/18 End: 10/20/23 Due: 10/20/24

A Study to Assess the Safety of Adacel® Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01040052 Org: User:
Start: 12/31/09 End: 04/30/10 Due: 04/30/11

Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age.

Phase: N/A Priority: Normal
NCT ID: NCT05513053 Org: User:
Start: 10/27/22 End: 10/27/23 Due: 10/27/24